Solid-Phase Peptide Synthesis: How Research Peptides Are Built
Research Guide

Solid-Phase Peptide Synthesis: How Research Peptides Are Built

Nearly every research peptide in circulation today is built by solid-phase peptide synthesis, a method introduced by Bruce Merrifield in the early 1960s and refined continuously since. The central idea is simple enough to state in one sentence: anchor the growing chain to an insoluble resin bead so that excess reagents can be washed away at every step. The consequences of that idea shape purity, cost, and which sequences are practical to produce at all.

Building a Chain One Residue at a Time

Synthesis runs from the C-terminus toward the N-terminus, the opposite direction from biological translation. Each cycle repeats three operations: deprotect the N-terminal amine of the resin-bound chain, couple the next protected amino acid using an activating reagent, then wash. Fmoc chemistry, which uses a base-labile protecting group, has become the dominant approach in most laboratories. Because the chain remains bound to the solid support throughout, purification between steps reduces to filtration and rinsing, which is the feature that made automation possible.

Cleavage and Where Impurities Come From

When the sequence is complete, a cleavage cocktail, typically trifluoroacetic acid with scavengers, releases the peptide from the resin and removes the side-chain protecting groups. No coupling step is perfectly efficient, and the small fraction of chains that fail to react in a given cycle produces deletion sequences missing one residue. These accumulate multiplicatively with chain length, which is why crude purity falls as sequences grow longer and why preparative HPLC is a routine rather than optional step. Aggregation of the growing chain on the resin, incomplete deprotection, and racemization contribute further related substances.

Why the Route Matters to the End User

Deletion and truncation products are chemically similar to the target sequence, which makes them difficult to separate and easy to miss with a single analytical method. This is the practical reason researchers look for orthogonal characterization, pairing chromatographic purity with mass confirmation, rather than relying on a purity figure alone. Analytical documentation for the sequences in our research peptide catalog is provided with that principle in mind.

The elegance of the method is also its limitation: what makes long sequences accessible also makes their impurity profiles more complex.

Research use only. This content is for informational and research purposes, is not medical advice, and these compounds are not for human or veterinary use.

Cart0
×

Research updates from Santa Cruz Peptides

New compounds, restocks and research guides — straight to your inbox.

For laboratory and research use only. Unsubscribe anytime.
Free Shipping On All Orders!